Nonalcoholic steatohepatitis (NASH) is a progressive form of fatty liver disease in which excess fat accumulation in the liver leads to inflammation and liver cell damage. Unlike alcoholic liver disease, NASH occurs in people who drink little to no alcohol. Over time, persistent inflammation can cause fibrosis (scarring) and, if untreated, may progress to cirrhosis or liver failure. The ICD-10 code for NASH is K75.81.
In its early stages, NASH often causes no noticeable symptoms. As inflammation and scarring increase, you may experience:
Several factors contribute to the development of NASH, including:
Don't wait to protect your liver. Contact GastroDoxs in Cypress today to schedule your NASH consultation. Our expert team offers patient-centered care, flexible scheduling, same-week appointments, and both in-person and virtual visits. Book your appointment now and start your personalized plan for lasting liver health.
We've successfully treated more than 1.5K patients, helping individuals improve their digestive health and overall well-being through expert, personalized care.
With over 20 years of experience, GastroDoxs has been a trusted provider of gastroenterology care, focusing on delivering the best outcomes for patients
Dr. Bharat Pothuri is a Board-Certified Gastroenterologist and Hepatologist. With extensive experience in digestive health, he specializes in advanced endoscopic procedures, chronic GI disorder management, and preventive care. Dr. Pothuri is dedicated to providing expert, patient-focused insights to help improve gut health and overall well-being.
The correct code for Nonalcoholic Steatohepatitis (NASH) is K75.81.
Under the older coding system, NASH was classified as 571.8.
The primary risk factors include obesity, type 2 diabetes, insulin resistance, high blood pressure, high cholesterol, and metabolic syndrome.
Diagnosis typically involves blood tests, liver imaging (ultrasound, MRI, FibroScan), and in some cases a liver biopsy to assess inflammation and fibrosis.
Yes. Without intervention, ongoing inflammation and fat accumulation can lead to liver scarring (cirrhosis) and permanent damage.
With early detection and appropriate lifestyle or medical interventions, many patients can slow, stop, or even reverse liver damage.
Yes. Several clinical trials are underway testing drugs that specifically target liver inflammation, fat accumulation, and fibrosis.
A Mediterranean-style diet rich in vegetables, fruits, whole grains, lean proteins, and healthy fats is often advised to reduce liver fat and inflammation.
Most patients benefit from liver tests every 6 to 12 months, although your physician may recommend a different schedule based on your individual risk factors.
Yes. GastroDoxs in Cypress provides specialized evaluation, personalized treatment plans, and ongoing support for patients with NASH.
